Vicapsys Life Sciences, Inc. (VICP)
↓ Download CSV| Metric (FY) | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Income | -$1.05M | -$984.8K | -$336.9K | -$765.8K | — | — |
| Net Income | -$1.18M | -$984.8K | -$236.9K | -$765.8K | -$1.41M | — |
| EPS (Diluted) | $-0.03 | $-0.03 | $-0.01 | — | — | — |
| Total Assets | $39.7K | $72.0K | $594.3K | $404.1K | $698.4K | — |
| Shareholders' Equity | -$1.93M | -$950.8K | -$121.7K | -$449.1K | $302.0K | -$253.7K |
| Cash & Equivalents | $9.4K | $14.1K | $217.3K | $1.3K | $264.2K | — |
| Operating Cash Flow | -$417.5K | -$238.2K | -$444.0K | -$262.9K | -$970.3K | — |
| Shares Outstanding | 32.07M | 31.19M | 19.75M | 17.48M | 17.48M | — |